Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideREGNRegeneron Pharmaceuticals
FinDog View：Neutral
UNHUnitedHealth Group
FinDog View：Bullish
| Metric | REGN | UNH |
|---|
| Close | 927.89 | 406.97 |
| Market Cap | $93.4B | $367B |
| 1M | +22.37% | +10.87% |
| P/E (TTM) | 19.5 | 23.0 |
| Forward P/E | 13.4 | 17.1 |
| P/E 5-Yr Percentile | 56 | 44 |
| P/S | 5.4 | 0.8 |
| P/B | 2.7 | 3.5 |
| Dividend Yield | 0.45% | 1.37% |
| Latest Quarter Revenue | $5.1B | $112B |
| Revenue YoY | +36.3% | +0.4% |
| Gross Margin | — | 88.1% |
| Latest Quarter EPS | 18.45 | 6.04 |
| Avg Post-Earnings Move | ±1.4% | ±3.1% |
| EPS Beat Rate | — | 1 / 1 |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.66% | 2.65% |
| 90-Day Net Insider Buying | −$6.5M | −$0.66M |
REGN · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
